NASDAQ$BTSG
Brightspring Health Services Inc · Q4 2025 earnings
Q4 2025 earnings · · Before market open
Briefing
BrightSpring Health Services reported Q4 2025, revenue of $3.55B, net income of $49.6M.
For Q4 2025, BrightSpring Health Services reported revenue of $3.55B, net income of $49.6M. Management discusses segment performance, capital allocation, and macro risks in the quarterly filing.
- Revenue $3.55B.
- Net income $49.6M.
- BrightSpring Health Services MD&A covers liquidity, credit, and operating priorities.
Headline financials
Revenue & EPS history
Brightspring Health Services Inc · Revenue · Quarterly
$3.55B
Forward guidance
The quarterly filing discusses operating priorities, capital returns, and sector risks; numeric multi-quarter bridges vary by issuer.
Tailwinds
- MD&A highlights liquidity, capital, and core business trends.
- Segment or product commentary supports the earnings narrative.
Headwinds
- Macro, rates, or input costs may pressure near-term margins.
- One-time items can affect year-over-year comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q4 2025
+4.4%
Avg return
Earnings day
+7.8%
Avg return
5 days after
+15.8%
Avg return
30 days after
75%
6 / 8 earnings
Positive
+16.6%
Q1 2025
Best reaction
-8.7%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +9.6% | +9.9% | +28.5% | |
| Q4 2025 | +3.2% | +4.6% | +5.5% | |
| Q3 2025 | +0.5% | -2.3% | +7.8% | |
| Q2 2025 | -4.9% | -0.7% | +14.7% | |
| Q1 2025 | +16.6% | +28.7% | +33.0% | |
| Q3 2024 | +15.2% | +22.6% | +28.9% | |
| Q2 2024 | -8.7% | -8.1% | +2.6% | |
| Q1 2024 | +3.8% | +7.7% | +5.5% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro